PMCB – PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference. PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, who will deliver a presentation about PharmaCyte and participate in virtual meetings with institutional investors throughout the conference, said, “We are extremely honored to present at H.C. Wainwright’s 23rd Annual Global Investment Conference. PharmaCyte is forever grateful to H.C. Wainwright for bringing institutional investors to our door so that we could present our story in two separate capital raises that generated about $90 million.”
PMCB stock is moving 25% upward in the premarket session.
CRDF – The shares of Cardiff Oncology were up 20% in the premarket session due to the cancer data.